Literature DB >> 10233701

Intrathymic function of the human cortical epithelial cell surface antigen gp200-MR6: single-chain antibodies to evolutionarily conserved determinants disrupt mouse thymus development.

D B Palmer1, T Crompton, M B Marandi, A J George, M A Ritter.   

Abstract

The mouse monoclonal antibody MR6 recognizes a 200 000 MW protein (gp200-MR6), which is expressed highly on human thymic cortical epithelial cells. The antigen is also expressed on some epithelial tumours and we have previously shown that MR6 inhibits the proliferation of the colon carcinoma cell lines HT29. However, the role of this molecule in the thymus is not known. In order to generate reagents that could be used in murine thymic functional studies we isolated antibodies specific to human gp200-MR6, using a phage display library expressing single-chain (sFv) antibodies. Three independent clones were isolated by panning with purified protein and their specificity was confirmed by immunohistochemistry, Western blotting and flow cytometry. In addition to human thymus, these phage antibodies also recognized the homologous antigen in mouse, pig and other species. Expressed as soluble sFv one of these clones inhibited the proliferation of HT29 cells and a mouse thymic epithelial cell line, suggesting that this antibody exhibits similar functional activity to MR6. In fetal thymic organ culture, thymocytes recovered from thymic lobes cultured in the presence of this sFv, were reduced in number fivefold compared with the control and the majority remained at the double-negative stage of development. These data indicate that gp200-MR6 plays an important role in thymocyte development. In addition, this is the first report to demonstrate that specific sFv can be used to study, and alter, thymic development. This work also highlights the advantage of phage antibody technology in selecting such reagents for functional assays.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233701      PMCID: PMC2326733          DOI: 10.1046/j.1365-2567.1999.00691.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  41 in total

1.  Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains.

Authors:  H R Hoogenboom; A D Griffiths; K S Johnson; D J Chiswell; P Hudson; G Winter
Journal:  Nucleic Acids Res       Date:  1991-08-11       Impact factor: 16.971

2.  The MAP kinase pathway controls differentiation from double-negative to double-positive thymocyte.

Authors:  T Crompton; K C Gilmour; M J Owen
Journal:  Cell       Date:  1996-07-26       Impact factor: 41.582

3.  Dimerization of Fab fragments enables ready screening of phage antibodies that affect hepatocyte growth factor/scatter factor activity on target cells.

Authors:  M Zaccolo; A P Griffiths; T D Prospero; G Winter; E Gherardi
Journal:  Eur J Immunol       Date:  1997-03       Impact factor: 5.532

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 5.  Fetal thymic organ cultures.

Authors:  E J Jenkinson; G Anderson
Journal:  Curr Opin Immunol       Date:  1994-04       Impact factor: 7.486

Review 6.  Making antibodies by phage display technology.

Authors:  G Winter; A D Griffiths; R E Hawkins; H R Hoogenboom
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

7.  Human IgA and IgG F(ab')2 that bind to staphylococcal protein A belong to the VHIII subgroup.

Authors:  E H Sasso; G J Silverman; M Mannik
Journal:  J Immunol       Date:  1991-09-15       Impact factor: 5.422

8.  By-passing immunization. Human antibodies from V-gene libraries displayed on phage.

Authors:  J D Marks; H R Hoogenboom; T P Bonnert; J McCafferty; A D Griffiths; G Winter
Journal:  J Mol Biol       Date:  1991-12-05       Impact factor: 5.469

9.  Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product.

Authors:  G I Evan; G K Lewis; G Ramsay; J M Bishop
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

10.  Interleukin 4 expressed in situ selectively alters thymocyte development.

Authors:  D B Lewis; C C Yu; K A Forbush; J Carpenter; T A Sato; A Grossman; D H Liggitt; R M Perlmutter
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

View more
  3 in total

1.  Novel human anti-claudin 1 mAbs inhibit hepatitis C virus infection and may synergize with anti-SRB1 mAb.

Authors:  Rolando Paciello; Richard A Urbanowicz; Gennaro Riccio; Emanuele Sasso; C Patrick McClure; Nicola Zambrano; Jonathan K Ball; Riccardo Cortese; Alfredo Nicosia; Claudia De Lorenzo
Journal:  J Gen Virol       Date:  2015-10-29       Impact factor: 3.891

2.  Expression and identification of recombinant soluble single-chain variable fragment of monoclonal antibody MC3.

Authors:  Feng-Tian He; Yong-Zhan Nie; Bao-Jun Chen; Tai-Dong Qiao; Dai-Ming Fan; Rong-Fen Li; Yun-Sheng Kang; Yan Zhang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

3.  Altered expression and endocytic function of CD205 in human dendritic cells, and detection of a CD205-DCL-1 fusion protein upon dendritic cell maturation.

Authors:  Matt Butler; Anne-Sophie Morel; William J Jordan; Efrem Eren; Susan Hue; Rachel E Shrimpton; Mary A Ritter
Journal:  Immunology       Date:  2006-12-08       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.